Skip to content

Common Stock at other companies

Amgen logo
AmgenAMGN
2.8B0.0%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1K0.0%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
300M0.0%
Savara logo
SavaraSVRA
$204K+17.9%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$29K-3.3%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
200M0.0%

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s common stock?
Upstream Bio, Inc. (UPB) reported common stock of $54K in Q1 2026.
How has Upstream Bio, Inc.'s common stock changed year-over-year?
Upstream Bio, Inc.'s common stock increased by 1.9% year-over-year, from $53K to $54K.
What is the long-term trend for Upstream Bio, Inc.'s common stock?
Over 2 years (2023 to 2025), Upstream Bio, Inc.'s common stock has grown at a 324.3% compound annual growth rate (CAGR), from $3K to $54K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).